Legal & General Grou (LGGNY) 13.7400 $LGGNY Legal &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Legal & General Grou (LGGNY) 13.7400 $LGGNY

Legal & General Group Plc Webcast Presentation Now Available for On-demand Viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference
PR Newswire Europe - Mon Mar 21, 7:01AM CDT
Legal & General Group Plc invites individual and institutional investors to log-on to view presentation
DB: 13.96 (-0.27)

Legal & General Group Plc to Present at the March 17, 2016 dbVIC - Deutsche Bank ADR Virtual Investor Conference
PR Newswire Europe - Mon Mar 14, 7:01AM CDT
Legal & General Group Plc invites investors to attend interactive virtual investor conference
DB: 13.96 (-0.27)

Directorate Change - Mark Gregory announces his intention to retire from Legal and General
M2 - Fri Feb 05, 6:20AM CST
Legal & General Group Plc ('Legal & General' or the 'Company' or 'Group' today announces that Mark Gregory, the Group Chief Financial Officer, has informed the Board of his intention to retire from the Group on 31 January 2017.

Directorate Change - Mark Gregory announces his intention to retire from Legal & General
M2 - Thu Feb 04, 5:22AM CST
Legal & General Group Plc ('Legal & General' or the 'Company' or 'Group' today announces that Mark Gregory, the Group Chief Financial Officer, has informed the Board of his intention to retire from the Group on 31 January 2017.

L&G to sell Suffolk Life to Curtis Banks
M2 - Fri Jan 15, 5:34AM CST
Legal & General Group plc has today announced the sale of Suffolk Life, one of the UK's leading providers and administrators of SIPPs, to Curtis Banks Group plc for GBP45 million. The acquisition is subject to an underwritten placing by Curtis Banks Group plc, and regulatory approval, both of which are expected in the first half of 2016.

Legal & General to use Internal Model
M2 - Mon Dec 07, 6:31AM CST
Legal & General Group Plc is pleased to confirm that it will be using its internal model in calculation of Solvency II capital requirements following notice received from the Prudential Regulation Authority.

John Stewart to Retire in 2016
M2 - Mon Nov 16, 11:25AM CST
Legal & General Group Plc -- John Stewart, Chairman of Legal & General Group Plc since 2010, has informed the Board of his intention to retire during 2016, following the identification and appointment of a successor. The Senior Independent Director will lead the Nominations Committee process for the identification and appointment of John's successor.

Boston Private elects Lizabeth H Zlatkus to its board of directors
M2 - Fri Jul 03, 3:02AM CDT
Boston Private Financial Holdings Inc (NASDAQ:BPFH) revealed on Friday that Lizabeth H. Zlatkus has been appointed to its board of directors and also to the board of Boston Private Bank & Trust Company, its wholly owned subsidiary.
BPFH: 12.35 (+0.01)

A.M. Best Affirms Ratings of Legal & General Group Plc's U.S. Operations
BusinessWire - Thu Jul 02, 11:05AM CDT
A.M. Best has affirmed the financial strength rating of A+ (Superior) and the issuer credit ratings of "aa-" of Banner Life Insurance Company (Banner Life) (Frederick, MD) and William Penn Life Insurance Company of New York (William Penn) (Garden City, NY). Banner Life and William Penn are collectively referred to as the Legal & General America Group (LGA) and represent the U.S. operations of the ultimate parent, Legal & General Group Plc (L&G), a worldwide insurance organization headquartered in the United Kingdom. The outlook for all ratings is stable.

A.M. Best Affirms Ratings of Legal & General Group Plc and Legal and General Assurance Society Limited
BusinessWire - Thu Jul 02, 10:51AM CDT
A.M. Best has affirmed the issuer credit rating (ICR) of "a" of the non-operating holding company, Legal & General Group Plc (L&G) (United Kingdom). Concurrently, all debt ratings on debt instruments issued or guaranteed by L&G have been affirmed. At the same time, A.M. Best has affirmed the financial strength rating of A+ (Superior) and the ICR of "aa-" of Legal and General Assurance Society Limited (LGAS) (United Kingdom), the largest operating insurance company in the L&G group. The outlook for all ratings is stable. (See below for a complete listing of debt ratings.)

United Kingdom Creditor Insurance Market 2015 - Key Trends and Opportunities to 2018
M2 - Wed May 27, 11:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ff9r5b/creditor) has announced the addition of the "Creditor Insurance in the UK - Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research on the creditor insurance industry in the UK, covering the market dynamics and competitive landscape through insights and forecasts. It also discusses key products and distribution channels, and gives an overview of the leading companies in the category. Summary - The report provides market analysis, information and insights into the UK creditor insurance business. - It also provides a snapshot of market size, market dynamics and market segmentation. - The report analyzes key drivers and the outlook for the market. - It summarizes news and regulatory developments in the category. Key Highlights - How did the creditor insurance market perform in the wake of the crisis until 2014? - What are the forecast market sizes and growth rates for creditor insurance to 2018? - How has the PPI mis-selling scandal impaired the category and what effects are still to be expected? - What market drivers are expected to have effects on the creditor insurance market and how will those drivers influence future growth? - Which companies have the largest market shares in the category and how important is creditor insurance in their protection portfolio? News and Deals - FCA fines Clydesdale Bank for failings in PPI complaint handling - PPI complaints numbers slowly start to level off - FCA to gather evidence on how the PPI complaints process is working Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 News and Deals 6 Regulation and Compliance 7 Economic Backdrop 8 Company Profiles 9 Statistics 10 Appendix Companies Mentioned - Allianz Plc - Aviva Plc - Axa UK Plc - Direct Line Insurance Group Plc - Genworth Financial Inc. - Great Lakes Reinsurance (UK) - Legal & General Group Plc - Lloyds Banking Group Plc - Pinnacle Insurance Plc - Royal & Sun Alliance Insurance Plc For more information visit http://www.researchandmarkets.com/research/ff9r5b/creditor
GNW: 3.84 (+0.02)

Income Protection and Critical Illness Insurance in the UK - Key Trends and Opportunities to 2018
M2 - Thu Apr 09, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xtd5j5/income_protection) has announced the addition of the "Income Protection and Critical Illness Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research into the income protection and critical illness insurance market in the UK, covering the market dynamics, outlook and competitive landscape. It provides estimates of the market size and projections of new business premiums, and discusses key products and distribution channels. The report also provides an overview of leading companies in the category, alongside details of any strategic initiatives undertaken. Key Highlights - Protection sales remained flat despite adverse market conditions - The income protection and critical illness category is expected to expand at a benign rate - The MMR is expected to highlight protection advice need - Insurers argue protection is the answer to reducing welfare costs - Technology is expected to change protection distribution - ABI shows a rise in protection claims payouts in 2013 Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 3.1 Market Size 3.2 Income Protection Insurance 3.3 Critical Illness Insurance 3.4 UK Long-Term Protection Market, New Regular Business Premiums by Category 3.5 The Number of IP and CI Product Sales 3.6 Claims 3.6.1 Claims outlook 3.7 Market Drivers 3.8 Market Outlook 3.9 Distribution Channels 4 Competitive Landscape 4.1 Review - The Best Performers of 2013 4.2 Income Protection and Critical Illness Insurance - SWOT Analysis 4.3 Product Innovation 5 Deals and News 5.1 Legal and General Revealed 60% of Claims are Cancer-Related 5.2 AIG Completes Purchase of Ageas Protect 5.3 ABI Publishes Updated Statement of Best Practice for CI Insurance 5.4 Aviva and Friends Life Agree Terms for GBP5.6 billion deal 5.5 Seven Families Campaign Begins 5.6 Lloyds Cuts Protection Advice Ahead of Intermediary Launch 5.7 Protection Surge Mitigates Aviva Annuity Attrition 5.8 TSB Bank Signs Protection Deal with Legal and General 6 Regulation and Compliance 6.1 Regulatory Changes 7 Economic Backdrop 7.1 Real GDP Growth 7.2 Demographics 7.3 Labor Market 7.4 Housing and Mortgage Market 7.5 Employment and Support Allowance and Incapacity Benefits Claimants 7.6 GDP per Capita and Household Disposable Income 8 Company Profiles 9 Statistics 9.1 Review Period: 2009-2013 9.2 Forecast Period: 2014-2018 10 Appendix Companies Mentioned - Ageas UK Ltd - Aviva Plc - Canada Life Ltd - Friends Life Group Ltd - Legal & General Group Plc - Liverpool Victoria Group - Lloyds Banking Group Plc - Partnership Assurance Group Plc - The Royal London Group - Unum Ltd For more information visit http://www.researchandmarkets.com/research/xt...protection

Term Life Insurance in the UK, Key Trends and Opportunities to 2018
M2 - Tue Jan 13, 3:41AM CST
Research and Markets (http://www.researchandmarkets.com/research/55k3wl/term_life) has announced the addition of the "Term Life Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research into the term life insurance market in the UK, covering the market dynamics, outlook and competitive landscape. It provides estimates of the market size and forecasts for the term life insurance market, and discusses key products and distribution channels. The report also provides an overview of leading companies in the category, along with details of strategic initiatives undertaken. Summary - The report provides market analysis and insights into the UK term life insurance business. - It also provides a snapshot of market size and market dynamics. - Furthermore, the report discusses key drivers, distribution channels and the outlook for the market. - It also summarizes deals, news and regulatory developments in the category. Key Highlights - Term life cover remains the most popular protection product. - Softening house-purchase lending activity may restrict new business sales growth;. - The MMR led to a shake-up in the protection advice market. - Providers are expected to simplify products and underwriting. - Budget changes expected to bring more attention to financial planning. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Deals and News 6 Regulation and Compliance 7 Economic Backdrop 8 Company Profiles 9 Statistics 10 Appendix Companies Mentioned - Aegon UK Plc - Ageas UK Ltd - Aviva Plc - Friends Life Group Ltd - Legal & General Group Plc - Liverpool Victoria Group - Lloyds Banking Group Plc - Prudential Plc - The Royal London Group - Scottish Friendly Assurance Society Ltd For more information visit http://www.researchandmarkets.com/research/55k3wl/term_life
PUK: 36.79 (-0.29)

Household Insurance in the UK, Key Trends and Opportunities to 2018
M2 - Fri Dec 05, 3:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/9bh9md/household) has announced the addition of the "Household Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research into the household insurance industry in the UK, covering the market dynamics, competitive landscape and consumer perspectives through insights and forecasts. It also discusses key products and distribution channels and gives an overview of the leading companies in the category, along with details of strategic initiatives undertaken. Key Highlights: - Household insurance premiums fell in both 2012 and 2013. - The category has remained profitable despite the decline in premium. - Rising expenses and shift in distribution model threaten future profitability. - Direct Line Group remains the largest household insurer as mid-tier companies gain market share. - Premium growth is expected to settle at 1.2% by 2018. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Porter's Five Forces Analysis 6 Deals and News 7 Regulation and Compliance 8 Consumer Perspective 9 Economic Backdrop 10 Company Profiles 11 Statistics Review Period 2009-2013 12 Appendix Companies Mentioned - Ace European Group Ltd - Ageas (UK) Ltd - Aviva Plc - Axa UK Plc - Direct Line Insurance Group Plc - Legal & General Group Plc - Lloyds Banking Group Plc - National Farmers Union Mutual Insurance Society - Royal & Sun Alliance Insurance Plc - Zurich Insurance Plc For more information visit http://www.researchandmarkets.com/research/9bh9md/household

Whole Life Insurance in the UK - Key Trends and Opportunities to 2018
M2 - Fri Nov 21, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/f6m2xz/whole_life) has announced the addition of the "Whole Life Insurance in the UK, Key Trends and Opportunities to 2018" report to their offering. This report is the result of extensive research into the whole life insurance market in the UK, covering the market dynamics, outlook and competitive landscape. It provides estimates of the market size and forecasts for the whole life insurance market, and discusses key products and distribution channels. The report also provides an overview of leading companies in the category, along with details of strategic initiatives undertaken. Key Highlights - Whole life insurance remains a hard product to sell. - Providers expected to promote versatility of the whole life cover. - Advisers are finding it difficult to engage clients on protection. - Individually underwritten plans are expected to increase in popularity. - Premium growth is expected to settle at 1.6% by 2018. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Competitive Landscape 5 Deals and News 6 Regulation and Compliance 7 Economic Backdrop 8 Company Profiles 9 Statistics 10 Appendix Companies Mentioned - Axa UK Plc - Aviva Plc - Engage Mutual Assurance - Legal & General Group Plc - Liverpool Victoria Group - Lloyds Banking Group Plc - Old Mutual Plc - Prudential Plc - The Royal London Group - Wesleyan Assurance Society For more information visit http://www.researchandmarkets.com/research/f6m2xz/whole_life
PUK: 36.79 (-0.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Breakthroughs in Lung Cancer Treatment with Reqorsa

Updated Category News Views 182

Innovative Advances in Lung Cancer Treatment The fight against lung cancer continues to evolve, showcasing promising advancements that bring new hope to patients. Genprex, Inc. is at the forefront of this battle with its revolutionary gene therapy known as Reqorsa. This cutting-edge treatment has been developed specifically to target KRAS mutation in non-small cell lung...

Continue Reading
EfTEN United Property Fund Reports October Earnings and NAV

Updated Category News Views 192

Insights into EfTEN United Property Fund's Recent Performance EfTEN United Property Fund demonstrated a net profit of 110 thousand euros for October, totaling 2.214 million euros for the first ten months of the year, marking a significant improvement from 724 thousand euros during the same period last year. This impressive financial outcome led to a distribution to...

Continue Reading
Cardiff Oncology Reports Encouraging Results in mCRC Trial

Updated Category News Views 236

Cardiff Oncology Reveals Promising Clinical Trial Results Cardiff Oncology, Inc. (Nasdaq: CRDF), a pioneering clinical-stage biotechnology company, has recently announced encouraging results from its ongoing CRDF-004 clinical trial. This randomized Phase 2 trial is investigating the effects of onvansertib in patients suffering from first-line RAS-mutated metastatic...

Continue Reading
Japan's Growing Casting Polyurethane Market and Its Future

Updated Category News Views 127

Japan's Casting Polyurethane Market: A Rising Force The Japan casting polyurethane market is on the verge of significant transformation, anticipated to elevate from a valuation of US$ 134.74 million to a remarkable US$ 248.24 million by 2033. This growth trajectory highlights a compelling compound annual growth rate (CAGR) of 7.08%, revealing the underlying strength...

Continue Reading
Hudson Technologies Faces Challenges Amid Downgrade by B.Riley

Updated Category News Views 353

B.Riley Downgrades Hudson Technologies Stock In a recent market statement, B.Riley has lowered its outlook on Hudson Technologies (NASDAQ: HDSN), shifting the stock rating from Buy to Neutral. This adjustment comes amidst new growth projections adjusted downwards from +16.6% to +8.5%. The modification in expectations has been linked to ongoing pressures on...

Continue Reading